drugset / Trial / NCT01968226
TRACER RGD-K5 Carotid Plaque Imaging Study
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to investigate the ability of the compound\[F-18\]RGD-K5, when used as a tracer during PET (positron emission tomography) imaging, to detect regions of unstable atherosclerotic plaque in the carotid artery of subjects being considered for carotid endarterectomy (CEA),and to confirm this ability through histological studies of samples of carotid artery plaques that will be collected during the planned carotid surgery.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-06
- Completion
- 2016-06
Outcome
Outcome not reported
Stopped: “Investigator left instititution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [F-18]RDG-K5 | Diagnostic / imaging agent | — | Intravenous |